Jupiter Life Line Hospitals
NSE: JLHL · ISIN INE682M01020 · Healthcare
₹293.35−0.10 (−0.03%)
Monday 9 November, 13:38 IST. Delayed. Source: Yahoo Finance.
Price chart
₹293.35 −0.10 (−0.03%) today
The day
- Previous close
- ₹293.45
- Open
- ₹294.90
- Day high
- ₹295.95
- Day low
- ₹290.05
Listed on NSE since 18 September 2023.
Key numbers
- Market value
- ₹9,616.90 Cr
- P/E (trailing)
- 54.53
- EPS (trailing)
- ₹5.38
- Price to book
- 5.88
- Dividend yield
- 0.07%
- Return on equity
- 12.1%
- Debt to equity
- 0.41
- Profit margin
- 11.5%
- Beta
- 0.10
- Volume today
- 15,370
- Average volume
- 1.74 L
Source: Yahoo Finance. Ratios use the latest reported (trailing twelve-month) figures.
Revenue and profit
| Year | Revenue | Net profit |
|---|---|---|
| FY23 | ₹892.54 Cr | ₹72.91 Cr |
| FY24 | ₹1,069.50 Cr | ₹176.61 Cr |
| FY25 | ₹1,301.32 Cr | ₹193.20 Cr |
| FY26 | ₹1,498.50 Cr | ₹194.01 Cr |
Source: Yahoo Finance, from annual reports. Consolidated where reported.
Quarterly results
| Quarter | Revenue | Net profit | Profit vs year ago |
|---|---|---|---|
| Q2 FY27Jul–Sep 2026 | ₹456 Cr | ₹56 Cr | −2.1% |
| Q1 FY27Apr–Jun 2026 | ₹411 Cr | ₹37 Cr | −14.5% |
| Q4 FY26Jan–Mar 2026 | ₹388 Cr | ₹51 Cr | +12.8% |
| Q3 FY26Oct–Dec 2025 | ₹365 Cr | ₹43 Cr | – |
| Q2 FY26Jul–Sep 2025 | ₹394 Cr | ₹57 Cr | – |
| Q1 FY26Apr–Jun 2025 | ₹348 Cr | ₹44 Cr | – |
Source: Jupiter Life Line Hospitals’s results filed with NSE, consolidated (the whole group). Net profit is the share of Jupiter Life Line Hospitals’s own shareholders where the filing separates it. Profit vs year ago compares with the same quarter a year earlier; – where that quarter is not on file or made a loss. EPS before Q2 FY27 is not shown: the share count changed (a bonus, split or merger), so it would not compare.
Download results (zip) A spreadsheet of the quarterly results and balance sheets, with the original filings from NSE.
Balance sheet
| As on | September 2026 | March 2026 |
|---|---|---|
| Fixed assets | ₹1,514 Cr | ₹1,505 Cr |
| Investments | ₹385 Cr | ₹486 Cr |
| Inventories | ₹36 Cr | ₹38 Cr |
| Owed by customers | ₹118 Cr | ₹76 Cr |
| Cash and equivalents | ₹45 Cr | ₹55 Cr |
| Total assets | ₹2,560 Cr | ₹2,383 Cr |
| Borrowings | ₹589 Cr | ₹509 Cr |
| Total liabilities | ₹930 Cr | ₹839 Cr |
| Shareholders’ equity | ₹1,630 Cr | ₹1,544 Cr |
Source: Jupiter Life Line Hospitals’s half-yearly statements of assets and liabilities filed with NSE, consolidated. Companies file these every September and March.
About Jupiter Life Line Hospitals
Jupiter Life Line Hospitals Limited, a multi-specialty hospital, provides health care services under the Jupiter brand in India. The company offers treatments in the areas of bariatric surgery, breast care center, cardiac surgery, cardiology, chest medicine, dental care, dermatology, endocrinology and diabetes, ENT, gastroenterology, general surgery and minimal access surgery, hematology and BMT, HPB and surgical gastroenterology, infectious diseases, internal medicine, interventional radiology, mental health, nephrology, neurology, neurosurgery, nutrition and dietetics, Obs and gynecology, oncology, ophthalmology, organ transplant, orthopedics, pediatrics, pain clinic, plastic and cosmetic surgery, rehabilitation, rheumatology, robotic knee replacement, robotic surgery, TAVI/TAVR, and urology. It also operates hotel under the Fortune Park Lake City Hotel brand in Thane. The company was incorporated in 2002 and is based in Mumbai, India.
- Industry
- Medical Care Facilities
- Based in
- Mumbai
- Employees
- 3,002
Company website · Profile: Yahoo Finance
In the news
All newsNo headlines name Jupiter Life Line Hospitals in the last day or two.
Dividends and corporate actions
All companies- Face Value Split (Sub-Division) - From Rs 10/- Per Share To Rs 2/- Per Share
Split · ex-date 24 July 2026
- Interim Dividend - Re 1 Per Share
Dividend · ex-date 22 May 2026
- Dividend - Re 1 Per Share
Dividend · ex-date 4 July 2025
- Dividend - Re 1 Per Share
Dividend · ex-date 2 August 2024
Source: NSE. Latest first.
Information only, not investment advice. Prices are delayed.